↓ Skip to main content

Dove Medical Press

Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

Overview of attention for article published in Infection and Drug Resistance, May 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
16 Mendeley
Title
Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
Published in
Infection and Drug Resistance, May 2019
DOI 10.2147/idr.s197735
Pubmed ID
Authors

Sara Thønnings, Filip Jansåker, Kim Oren Gradel, Bjarne Styrishave, Jenny Dahl Knudsen

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 13%
Student > Postgraduate 2 13%
Researcher 2 13%
Student > Ph. D. Student 2 13%
Lecturer 1 6%
Other 3 19%
Unknown 4 25%
Readers by discipline Count As %
Medicine and Dentistry 5 31%
Pharmacology, Toxicology and Pharmaceutical Science 3 19%
Biochemistry, Genetics and Molecular Biology 1 6%
Veterinary Science and Veterinary Medicine 1 6%
Immunology and Microbiology 1 6%
Other 1 6%
Unknown 4 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2019.
All research outputs
#18,020,520
of 23,146,350 outputs
Outputs from Infection and Drug Resistance
#944
of 1,704 outputs
Outputs of similar age
#247,030
of 350,403 outputs
Outputs of similar age from Infection and Drug Resistance
#25
of 58 outputs
Altmetric has tracked 23,146,350 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,704 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,403 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.